The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator.

A small biopharmaceutical firm was getting a big boost Tuesday after Biogen agreed to buy it for $5.6 billion.

In this article, we will list the 5 Best Pharma Stocks to Invest In Now. Please visit 7 Best Pharma Stocks to Invest In Now ...

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) shares are surging today, last seen 44.4% higher to trade at $39.90 on news that ...

Agios Pharmaceuticals Inc AGIO shares are trading sharply higher Tuesday afternoon after the company said it will pursue U.S.

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best high growth healthcare stocks to buy now. Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced on March 24 a set of strategic efforts ...

It's reaching into its coffers for a $5.6 billion acquisition.

While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has necessarily ...

Biogen has agreed to acquire ​Apellis ​Pharmaceuticals ​for about $5.6 billion in cash, expanding its portfolio ⁠of ...

ORIC Pharmaceuticals (NASDAQ:ORIC) fell 27% Tuesday after the company announced the selection of rinzimetostat’s recommended Phase 3 dose in combination with da ...

Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...

Jared Holz, Mizuho, joins 'Fast Money' to talk what's ahead for pharmaceutical companies in the obesity drug market.